Showing results (71-80 of 80) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 80 results.
Cancers|June 24, 2022
Low-Dose Metronomic Topotecan and Pazopanib (TOPAZ) in Children with Relapsed or Refractory Solid Tumors: A C17 Canadian Phase I Clinical TrialArif Manji, Yvan Samson, Rebecca J Deyell, et al.
Cancer Research|April 19, 2006
Inhibition of cyclooxygenase-2 disrupts tumor vascular mural cell recruitment and survival signalingAlice Lee, Jason Frischer, Anna Serur, et al.
Neuro-Oncology|May 22, 2014
Phase 2 study of safety and efficacy of nimotuzumab in pediatric patients with progressive diffuse intrinsic pontine gliomaUte Bartels, Johannes Wolff, Lia Gore, et al.
Cancer|September 14, 2022
Early-phase clinical trial eligibility and response evaluation criteria for refractory, relapsed, or progressive neuroblastoma: A consensus statement from the National Cancer Institute Clinical Trials Planning MeetingJulie R Park, Judith G Villablanca, Barbara Hero, et al.
Canadian Journal of Kidney Health and Disease|March 9, 2017
Design and Methods of the Pan-Canadian Applying Biomarkers to Minimize Long-Term Effects of Childhood/Adolescent Cancer Treatment (ABLE) Nephrotoxicity Study: A Prospective Observational Cohort StudyKelly R McMahon, Shahrad Rod Rassekh, Kirk R Schultz, et al.
EMBO Molecular Medicine|August 20, 2010
Selective targeting of neuroblastoma tumour-initiating cells by compounds identified in stem cell-based small molecule screensKristen M Smith, Alessandro Datti, Mayumi Fujitani, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 19, 2008
Phase I trial and pharmacokinetic study of bevacizumab in pediatric patients with refractory solid tumors: a Children's Oncology Group StudyJulia L Glade Bender, Peter C Adamson, Joel M Reid, et al.
British Journal of Clinical Pharmacology|May 6, 2026
Metabolomic investigation of cisplatin-induced acute kidney injury in paediatric cancer patientsYong Jin Lim, Amy Thachil, Kelly McMahon, et al.
European Journal of Cancer (Oxford, England : 1990)|June 25, 2018
Phase I results of a phase I/II study of weekly nab-paclitaxel in paediatric patients with recurrent/refractory solid tumours: A collaboration with innovative therapies for children with cancerLucas Moreno, Michela Casanova, Julia C Chisholm, et al.
The Lancet. Oncology|April 20, 2013
Methylation of the TERT promoter and risk stratification of childhood brain tumours: an integrative genomic and molecular studyPedro Castelo-Branco, Sanaa Choufani, Stephen Mack, et al.
Pageof 8